feed,title,long_url,short_url
Benzinga,Eiger Shares Tumble Despite Phase 3 Study Meets Primary Endpoint,https://benzinga.com/general/biotech/22/12/30006991/eiger-shares-tumble-despite-phase-3-study-meets-primary-endpoint,https://da.gd/p8YO
